|
Module 4. Post-Marketing Surveillance
|
Startdate: 4 October 2010 - 6 October 2010 Duration: 3 Day(s) Location: Medicademy Lersø Parkallé 101 2100 København Ø
Purpose:The overall aim of this module is to make students able to: - understand what constitutes post-marketing surveillance, including the definition and scope of post-marketing surveillance, risk management plans, post authorisation safety studies, types of studies, post-marketing spontaneous reporting, signal detection, tools for signal detection, interpretation of findings, actions following a confirmed signal, SPC update, crisis management, execution of recalls and product life cycle management - analyse and post authorisation safety studies and enterpret signals and findings, etc. - use and prepare risk management plans, update SPCs and execute recalls and manage life cycle management in a highly dynamic and constantly changing environment Content:· Overview of post-marketing surveillance
· Post-marketing spontaneous reporting
· Databases for spontaneous reporting
· Tools for signal detection
· Current practice of agencies in signal detection
· Interpretation of findings and documentation hereof
· Actions following a confirmed signal
· SPC update and harmonisation
· Crisis managment/product recall
· Product life cycle management Prerequisites:The recommended entry qualifications of participants are two years of experience within Pharmacovigilance or similar entry qualifications. Please note that applications will be reviewed on a first come first served basis. Other participants will be considered on a case-by-case basis. Approximately 25 participants will be admitted to each module. For some modules, prior attendance at specific modules, or equal experience, is recommended. This appears from the description of the individual modules. |
|
Price: DKK 17,000 (approx. EUR 2,285 ) + 25% VAT, meals and course materials inclusive. Accomodation exclusive.
Registration deadline: 6 September 2010 Exam:4 November 2010 Please remember that you can take the exam in your country. Further information on the exam will follow. Please note: The course design of Medicademy Pharmacovigilance is highly flexible, and each module is a complete module, which can either be taken as an individual module or as one module in a series of modules - and in any arbitrary order. |
|
Register:
DKK 17,000.00 VAT, 25% DKK 4,250.00 Incl. VAT DKK 21,250.00
|
|
Agenda
Day 1
Introduction
Overview of post-marketing surveillance
Risk Management Plans
• Risk Management is a global theme
• Risk based approach to PV
• Proactive PV
• Risk minimisation
• (guideline pre-read)
Coffee/Tea
PASS (Post Authorisation Safety Studies)
Definition of PASS
Interventional trials
Non-interventional studies
Legislation: Non-interventional
Volume 9A
Commitment from approval process
Company strategy to comply with legislations and keep overview
Lunch
Workshop: Challenges in enrolment of patients and data collection
Post-marketing spontaneous reporting
ICSR’s
HCPs
Consumer reporting
Patients supporting programmes
Literature
Websites
The role of the media in stimulating reports (concrete examples)
Quality/validity of reports
Coffee/tea
Signal detection
Legislation
Definition of signal
Definition of acceptable risk (benefit)
Workshop on Risk Management Plans
Case study on Thalidomide
Develop risk minimisation plan based on data
Compare with actual
Discussion/evaluation
Day 2
Summary of day 1
Databases for spontaneous reporting
Company safety database
External safety databases
National competent authority databases
FDA databases
WHO databases
EudraVigilance
Tools for signal detection
Statistics
Software for signal detection
Interpretation of findings and documentation hereof
Signal Management & Follow-Up
Practical examples from EudraVigilance Data Management System or national databases
Lunch
Workshop on signal detection
Coffee/tea
Actions following a confirmed signal
Different scenarios (from SPC update to crisis management)
SPC update and harmonisation processes
Reporting of signals
PSURs
RMPs
Regulatory Perspective
Dinner
Day 3
Summary of day 2 and introduction to day 3
Workshop on crisis management (good and bad examples)
Coffee/tea
Crisis management/product recall
Handling of a safety crisis
Decision process – relevant parties
Communication (Agencies, DHCP, stock markets, internally)
Role of legal
Execution of recall
Relevant parties
Evaluation of process
Communication of Risk
Counterfeit
Product life cycle management
Changes to target population or indication formulation
Consideration for safety surveillance
Signal detection
PSURs, RMPs
Older products versus recently approved products
What to do when a product has been taken off the market
What is new in PAPA & New Horizons?
Summary of Module 4
Evaluation, Feedback and Goodbye